Concepts (270)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Superoxide Dismutase | 23 | 2013 | 213 | 2.190 |
Why?
|
Amyotrophic Lateral Sclerosis | 23 | 2019 | 474 | 1.810 |
Why?
|
Muscular Dystrophy, Facioscapulohumeral | 4 | 2024 | 38 | 1.370 |
Why?
|
Paralysis, Hyperkalemic Periodic | 6 | 2020 | 6 | 1.300 |
Why?
|
Mutation | 23 | 2019 | 2427 | 1.190 |
Why?
|
Muscle, Skeletal | 11 | 2022 | 673 | 1.060 |
Why?
|
Sodium Channels | 7 | 2012 | 20 | 0.910 |
Why?
|
Catatonia | 1 | 2023 | 5 | 0.890 |
Why?
|
Leukoencephalopathies | 1 | 2023 | 24 | 0.880 |
Why?
|
RNA-Binding Protein FUS | 5 | 2019 | 50 | 0.810 |
Why?
|
Motor Neuron Disease | 5 | 2008 | 29 | 0.750 |
Why?
|
Myotonia | 3 | 2008 | 3 | 0.580 |
Why?
|
Superoxide Dismutase-1 | 14 | 2016 | 134 | 0.500 |
Why?
|
Muscle Contraction | 3 | 2020 | 198 | 0.490 |
Why?
|
Muscle Fatigue | 1 | 2012 | 45 | 0.400 |
Why?
|
Potassium | 4 | 2020 | 109 | 0.390 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2011 | 23 | 0.380 |
Why?
|
Paralyses, Familial Periodic | 4 | 1999 | 4 | 0.370 |
Why?
|
Metals | 4 | 2009 | 63 | 0.370 |
Why?
|
Motor Neurons | 7 | 2019 | 206 | 0.360 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 2 | 2009 | 248 | 0.360 |
Why?
|
Axonal Transport | 4 | 2013 | 31 | 0.330 |
Why?
|
Mutation, Missense | 4 | 2015 | 179 | 0.330 |
Why?
|
Animals | 32 | 2023 | 19614 | 0.320 |
Why?
|
Copper | 3 | 2007 | 49 | 0.300 |
Why?
|
Zinc | 3 | 2005 | 90 | 0.300 |
Why?
|
Point Mutation | 5 | 2005 | 162 | 0.290 |
Why?
|
Disulfides | 2 | 2009 | 62 | 0.290 |
Why?
|
Mice | 19 | 2023 | 10259 | 0.280 |
Why?
|
Muscle Fibers, Skeletal | 2 | 2020 | 84 | 0.280 |
Why?
|
Humans | 40 | 2024 | 59339 | 0.270 |
Why?
|
Homeodomain Proteins | 3 | 2022 | 254 | 0.260 |
Why?
|
Amino Acid Substitution | 7 | 2008 | 253 | 0.260 |
Why?
|
NAV1.4 Voltage-Gated Sodium Channel | 2 | 2015 | 2 | 0.250 |
Why?
|
Sodium | 3 | 2015 | 60 | 0.240 |
Why?
|
Cytoplasm | 4 | 2014 | 273 | 0.230 |
Why?
|
RNA, Messenger | 5 | 2018 | 1470 | 0.230 |
Why?
|
Canavan Disease | 1 | 2023 | 11 | 0.210 |
Why?
|
Inclusion Bodies | 2 | 2016 | 14 | 0.210 |
Why?
|
Heart | 2 | 2023 | 274 | 0.210 |
Why?
|
Heart Rate | 1 | 2023 | 304 | 0.200 |
Why?
|
Myoblasts | 1 | 2022 | 63 | 0.190 |
Why?
|
Neurons | 3 | 2018 | 858 | 0.180 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2022 | 135 | 0.170 |
Why?
|
Cell Line | 6 | 2022 | 2014 | 0.170 |
Why?
|
Mutagenesis, Site-Directed | 4 | 2002 | 255 | 0.160 |
Why?
|
Golgi Apparatus | 1 | 2019 | 64 | 0.160 |
Why?
|
Spinal Cord | 5 | 2016 | 195 | 0.160 |
Why?
|
Mice, Transgenic | 7 | 2016 | 1221 | 0.160 |
Why?
|
Mutant Proteins | 2 | 2009 | 105 | 0.160 |
Why?
|
Dyneins | 3 | 2008 | 117 | 0.160 |
Why?
|
Calcium | 2 | 2020 | 555 | 0.150 |
Why?
|
Endoplasmic Reticulum | 1 | 2019 | 167 | 0.150 |
Why?
|
Protein Structure, Secondary | 6 | 2008 | 249 | 0.150 |
Why?
|
Cells, Cultured | 6 | 2022 | 2103 | 0.150 |
Why?
|
Protein Biosynthesis | 1 | 2019 | 293 | 0.140 |
Why?
|
Recombinant Proteins | 5 | 2008 | 695 | 0.140 |
Why?
|
Huntington Disease | 1 | 2018 | 146 | 0.140 |
Why?
|
Kinetics | 5 | 2008 | 733 | 0.140 |
Why?
|
Trans-Activators | 2 | 2011 | 295 | 0.130 |
Why?
|
Muscles | 2 | 1988 | 171 | 0.130 |
Why?
|
Binding Sites | 5 | 2009 | 875 | 0.130 |
Why?
|
Diaphragm | 1 | 2015 | 23 | 0.130 |
Why?
|
Mass Spectrometry | 4 | 2013 | 285 | 0.130 |
Why?
|
Actins | 2 | 1988 | 260 | 0.130 |
Why?
|
Models, Molecular | 6 | 2009 | 1125 | 0.120 |
Why?
|
Oxidation-Reduction | 2 | 2008 | 304 | 0.120 |
Why?
|
Protein Conformation | 5 | 2009 | 766 | 0.120 |
Why?
|
Cysteine | 2 | 2007 | 107 | 0.120 |
Why?
|
Dithiothreitol | 2 | 2005 | 18 | 0.120 |
Why?
|
Electrophysiology | 3 | 2008 | 89 | 0.120 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2014 | 37 | 0.110 |
Why?
|
Middle Aged | 3 | 2024 | 16246 | 0.110 |
Why?
|
Genetic Variation | 2 | 2009 | 367 | 0.110 |
Why?
|
DNA Helicases | 2 | 2016 | 187 | 0.110 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2013 | 30 | 0.110 |
Why?
|
Patents as Topic | 1 | 2012 | 6 | 0.110 |
Why?
|
Nerve Degeneration | 1 | 2013 | 68 | 0.100 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 125 | 0.100 |
Why?
|
Potassium Channels | 1 | 2012 | 53 | 0.100 |
Why?
|
Repressor Proteins | 1 | 2014 | 336 | 0.100 |
Why?
|
Transfection | 5 | 2008 | 673 | 0.100 |
Why?
|
Monensin | 1 | 2011 | 4 | 0.100 |
Why?
|
Carrier Proteins | 1 | 2016 | 710 | 0.100 |
Why?
|
Albuterol | 1 | 2011 | 20 | 0.100 |
Why?
|
Capsaicin | 1 | 2011 | 22 | 0.090 |
Why?
|
Cell Lineage | 2 | 2023 | 250 | 0.090 |
Why?
|
Microtubule-Associated Proteins | 2 | 2009 | 111 | 0.090 |
Why?
|
Electric Stimulation | 1 | 2011 | 139 | 0.090 |
Why?
|
Cell Nucleus | 4 | 2018 | 603 | 0.090 |
Why?
|
Male | 4 | 2024 | 27518 | 0.090 |
Why?
|
Disease Models, Animal | 5 | 2022 | 2062 | 0.090 |
Why?
|
Oxidative Stress | 2 | 2010 | 280 | 0.090 |
Why?
|
Phenotype | 3 | 2008 | 1157 | 0.090 |
Why?
|
Anilino Naphthalenesulfonates | 1 | 2009 | 2 | 0.080 |
Why?
|
Holoenzymes | 1 | 2009 | 3 | 0.080 |
Why?
|
Titrimetry | 1 | 2009 | 11 | 0.080 |
Why?
|
Electrophoresis | 1 | 2009 | 16 | 0.080 |
Why?
|
Crystallography, X-Ray | 6 | 2008 | 422 | 0.080 |
Why?
|
Green Fluorescent Proteins | 1 | 2010 | 353 | 0.080 |
Why?
|
Cell Line, Tumor | 2 | 2019 | 1370 | 0.080 |
Why?
|
Sensitivity and Specificity | 2 | 2008 | 1093 | 0.080 |
Why?
|
Detergents | 1 | 2008 | 35 | 0.070 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2009 | 427 | 0.070 |
Why?
|
Neurodegenerative Diseases | 1 | 2009 | 127 | 0.070 |
Why?
|
Gene Expression Regulation | 3 | 2011 | 1537 | 0.070 |
Why?
|
Zebrafish | 1 | 2010 | 323 | 0.070 |
Why?
|
Action Potentials | 2 | 2015 | 103 | 0.070 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2011 | 418 | 0.070 |
Why?
|
Multienzyme Complexes | 1 | 2007 | 77 | 0.070 |
Why?
|
Enzyme Stability | 2 | 2007 | 46 | 0.070 |
Why?
|
Saccharomyces cerevisiae | 1 | 2011 | 529 | 0.070 |
Why?
|
Protein Folding | 1 | 2008 | 256 | 0.070 |
Why?
|
Adult | 5 | 2024 | 15741 | 0.070 |
Why?
|
Polymorphism, Genetic | 2 | 1997 | 197 | 0.070 |
Why?
|
Calorimetry, Differential Scanning | 2 | 2005 | 29 | 0.070 |
Why?
|
Membrane Potentials | 2 | 2015 | 136 | 0.070 |
Why?
|
Genes | 1 | 1986 | 96 | 0.060 |
Why?
|
Cloning, Molecular | 2 | 2002 | 385 | 0.060 |
Why?
|
Histidine | 1 | 2005 | 31 | 0.060 |
Why?
|
Protein Structure, Quaternary | 1 | 2005 | 101 | 0.060 |
Why?
|
Arginine | 1 | 2005 | 113 | 0.060 |
Why?
|
Molecular Chaperones | 1 | 2005 | 97 | 0.060 |
Why?
|
Cyclopropanes | 1 | 2024 | 41 | 0.060 |
Why?
|
Transforming Growth Factor beta | 1 | 2004 | 162 | 0.060 |
Why?
|
Disease Progression | 1 | 2008 | 1040 | 0.050 |
Why?
|
Pyridines | 1 | 2024 | 98 | 0.050 |
Why?
|
RNA Helicases | 2 | 2016 | 88 | 0.050 |
Why?
|
Molecular Weight | 3 | 2008 | 187 | 0.050 |
Why?
|
Oligodendroglia | 1 | 2023 | 33 | 0.050 |
Why?
|
Bicarbonates | 1 | 2003 | 13 | 0.050 |
Why?
|
Myelin Sheath | 1 | 2023 | 35 | 0.050 |
Why?
|
Iodoacetamide | 1 | 2002 | 3 | 0.050 |
Why?
|
Hydrogen Peroxide | 1 | 2003 | 74 | 0.050 |
Why?
|
Rats | 2 | 1997 | 1907 | 0.050 |
Why?
|
Proteomics | 2 | 2019 | 252 | 0.050 |
Why?
|
Double-Blind Method | 1 | 2024 | 684 | 0.050 |
Why?
|
Organ Specificity | 1 | 2002 | 179 | 0.050 |
Why?
|
Aging | 1 | 2008 | 723 | 0.050 |
Why?
|
PAX3 Transcription Factor | 1 | 2022 | 13 | 0.050 |
Why?
|
Insecta | 1 | 2002 | 38 | 0.050 |
Why?
|
Protein Denaturation | 1 | 2002 | 65 | 0.050 |
Why?
|
Muscular Atrophy | 1 | 2022 | 26 | 0.050 |
Why?
|
Mammals | 1 | 2023 | 204 | 0.050 |
Why?
|
Protein Engineering | 1 | 2002 | 77 | 0.050 |
Why?
|
Thermodynamics | 1 | 2002 | 194 | 0.050 |
Why?
|
DNA Primers | 1 | 2002 | 291 | 0.050 |
Why?
|
Muscle Development | 1 | 2022 | 53 | 0.050 |
Why?
|
Regeneration | 1 | 2022 | 90 | 0.050 |
Why?
|
Central Nervous System | 1 | 2023 | 191 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2022 | 1295 | 0.050 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2002 | 91 | 0.050 |
Why?
|
Recovery of Function | 1 | 2022 | 262 | 0.040 |
Why?
|
Female | 4 | 2024 | 30835 | 0.040 |
Why?
|
Temperature | 2 | 2004 | 300 | 0.040 |
Why?
|
Epigenesis, Genetic | 1 | 2023 | 351 | 0.040 |
Why?
|
Coat Protein Complex I | 1 | 2019 | 5 | 0.040 |
Why?
|
Arsenites | 1 | 2019 | 7 | 0.040 |
Why?
|
Cytoplasmic Granules | 1 | 2019 | 53 | 0.040 |
Why?
|
Mitochondrial Myopathies | 1 | 1998 | 3 | 0.040 |
Why?
|
Cytochrome b Group | 1 | 1998 | 19 | 0.040 |
Why?
|
Signal Transduction | 2 | 2009 | 2890 | 0.040 |
Why?
|
Trinucleotide Repeat Expansion | 1 | 2018 | 33 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2004 | 1128 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 1998 | 76 | 0.040 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2018 | 155 | 0.040 |
Why?
|
Protein Binding | 3 | 2009 | 1550 | 0.040 |
Why?
|
Models, Biological | 2 | 2009 | 1140 | 0.040 |
Why?
|
Isoleucine | 1 | 1997 | 9 | 0.040 |
Why?
|
Valine | 1 | 1997 | 30 | 0.040 |
Why?
|
Hyperkalemia | 1 | 1997 | 23 | 0.040 |
Why?
|
Nucleic Acid Hybridization | 2 | 1988 | 104 | 0.040 |
Why?
|
Oligonucleotides, Antisense | 1 | 2018 | 133 | 0.030 |
Why?
|
Phosphorylation | 2 | 2013 | 861 | 0.030 |
Why?
|
HeLa Cells | 1 | 2018 | 527 | 0.030 |
Why?
|
Ion Channel Gating | 1 | 1997 | 44 | 0.030 |
Why?
|
Mutagenesis, Insertional | 1 | 1997 | 92 | 0.030 |
Why?
|
RNA Recognition Motif Proteins | 1 | 2016 | 5 | 0.030 |
Why?
|
Poly-ADP-Ribose Binding Proteins | 1 | 2016 | 8 | 0.030 |
Why?
|
Plasmids | 2 | 2008 | 282 | 0.030 |
Why?
|
Cell Membrane Permeability | 1 | 1996 | 39 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 1997 | 142 | 0.030 |
Why?
|
Patch-Clamp Techniques | 1 | 1996 | 125 | 0.030 |
Why?
|
Gene Silencing | 1 | 2018 | 377 | 0.030 |
Why?
|
Protein Subunits | 2 | 2008 | 164 | 0.030 |
Why?
|
COS Cells | 2 | 2007 | 174 | 0.030 |
Why?
|
Horse Diseases | 1 | 1995 | 19 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2024 | 5142 | 0.030 |
Why?
|
Horses | 2 | 2008 | 49 | 0.030 |
Why?
|
Macromolecular Substances | 2 | 2004 | 160 | 0.030 |
Why?
|
Decapodiformes | 1 | 2013 | 14 | 0.030 |
Why?
|
Dimerization | 2 | 2004 | 146 | 0.030 |
Why?
|
Myosins | 1 | 2014 | 109 | 0.030 |
Why?
|
RNA Precursors | 1 | 2013 | 74 | 0.030 |
Why?
|
DNA Methylation | 1 | 2014 | 275 | 0.030 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 851 | 0.030 |
Why?
|
Exons | 1 | 2013 | 193 | 0.020 |
Why?
|
Protein Structure, Tertiary | 2 | 2004 | 663 | 0.020 |
Why?
|
RNA Splicing | 1 | 2013 | 161 | 0.020 |
Why?
|
Histones | 1 | 2014 | 463 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2008 | 1582 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2013 | 846 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2013 | 324 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2008 | 1977 | 0.020 |
Why?
|
Adolescent | 1 | 2022 | 5918 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2013 | 577 | 0.020 |
Why?
|
Base Sequence | 2 | 1998 | 1312 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2013 | 659 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2011 | 502 | 0.020 |
Why?
|
Thyroglobulin | 1 | 2008 | 9 | 0.020 |
Why?
|
tau Proteins | 1 | 2009 | 104 | 0.020 |
Why?
|
Static Electricity | 1 | 2009 | 165 | 0.020 |
Why?
|
Databases, Protein | 1 | 2008 | 46 | 0.020 |
Why?
|
Solvents | 1 | 2008 | 58 | 0.020 |
Why?
|
Dynactin Complex | 1 | 2008 | 6 | 0.020 |
Why?
|
Metalloendopeptidases | 1 | 1988 | 22 | 0.020 |
Why?
|
Cell Compartmentation | 1 | 1988 | 34 | 0.020 |
Why?
|
Cell Fusion | 1 | 1988 | 45 | 0.020 |
Why?
|
Chickens | 1 | 1988 | 91 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2009 | 189 | 0.020 |
Why?
|
Dipeptides | 1 | 1988 | 62 | 0.020 |
Why?
|
Cattle | 1 | 2008 | 306 | 0.020 |
Why?
|
Chromatin | 1 | 2013 | 594 | 0.020 |
Why?
|
Synapses | 1 | 2009 | 177 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2008 | 119 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2008 | 243 | 0.020 |
Why?
|
Solubility | 1 | 2008 | 173 | 0.020 |
Why?
|
Chromatography, Affinity | 1 | 2007 | 48 | 0.020 |
Why?
|
Genetic Diseases, Inborn | 1 | 2007 | 36 | 0.020 |
Why?
|
Serine | 1 | 2007 | 83 | 0.020 |
Why?
|
Cell Division | 1 | 1988 | 442 | 0.020 |
Why?
|
Axons | 1 | 2007 | 120 | 0.020 |
Why?
|
Chick Embryo | 1 | 1986 | 50 | 0.020 |
Why?
|
DNA Restriction Enzymes | 1 | 1986 | 35 | 0.020 |
Why?
|
Transition Temperature | 1 | 2005 | 5 | 0.020 |
Why?
|
Deuterium Exchange Measurement | 1 | 2005 | 18 | 0.020 |
Why?
|
Smad2 Protein | 1 | 2004 | 7 | 0.010 |
Why?
|
Smad3 Protein | 1 | 2004 | 18 | 0.010 |
Why?
|
Molecular Conformation | 1 | 2004 | 132 | 0.010 |
Why?
|
Scattering, Radiation | 1 | 2004 | 72 | 0.010 |
Why?
|
Hot Temperature | 1 | 2004 | 125 | 0.010 |
Why?
|
Algorithms | 1 | 2008 | 986 | 0.010 |
Why?
|
Amyloid | 1 | 2003 | 62 | 0.010 |
Why?
|
Models, Chemical | 1 | 2003 | 133 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2003 | 353 | 0.010 |
Why?
|
Water | 1 | 2003 | 295 | 0.010 |
Why?
|
Biomarkers, Tumor | 1 | 2004 | 454 | 0.010 |
Why?
|
Polymers | 1 | 2004 | 315 | 0.010 |
Why?
|
Genetic Vectors | 1 | 1986 | 813 | 0.010 |
Why?
|
Electron Transport Complex III | 1 | 1998 | 5 | 0.010 |
Why?
|
Coenzymes | 1 | 1998 | 6 | 0.010 |
Why?
|
Mitochondria, Muscle | 1 | 1998 | 13 | 0.010 |
Why?
|
Phosphocreatine | 1 | 1998 | 24 | 0.010 |
Why?
|
Ubiquinone | 1 | 1998 | 16 | 0.010 |
Why?
|
Folic Acid | 1 | 1998 | 58 | 0.010 |
Why?
|
Conserved Sequence | 1 | 1998 | 171 | 0.010 |
Why?
|
Phosphates | 1 | 1998 | 88 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1998 | 357 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1998 | 290 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2005 | 3190 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1998 | 292 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 1996 | 16 | 0.010 |
Why?
|
Evolution, Molecular | 1 | 1998 | 291 | 0.010 |
Why?
|
Family Health | 1 | 1996 | 68 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 1996 | 396 | 0.010 |
Why?
|
Models, Genetic | 1 | 1995 | 253 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 1995 | 500 | 0.010 |
Why?
|
Exercise | 1 | 1998 | 913 | 0.010 |
Why?
|
Child | 1 | 1997 | 4300 | 0.000 |
Why?
|
Time Factors | 1 | 1995 | 3567 | 0.000 |
Why?
|